作为一种新型分离酶抑制剂,沃利辛B在老鼠异种移植模型中具有强大的抗癌功效
Qinwei Zhu1, Liyang Du2, Juhong Wu1
1College of Chemistry, Fuzhou University, Fuzhou 350108, China.
Biochemical pharmacology
|August 22, 2024
概括
瓦利辛B及其类似物是人类分离酶的强有力的抑制剂,这是细胞分裂中的关键酶. 这些化合物在临床前模型中显示出显著的抗瘤疗效,突出显示了它们在癌症治疗中的治疗潜力.
科学领域:
- 细胞生物学 细胞生物学
- 生物化学 生物化学
- 药理学 药理学是指药理学的学科.
背景情况:
- 染色体分离对于细胞分裂至关重要,并依赖于及时的染色体凝聚溶解.
- 分离酶,一种囊蛋白酶,在线粒分裂过程中分裂凝聚素的克莱辛子单元,使其成为有前途的癌症治疗标.
- 获得活性人体分离酶的困难阻碍了抑制剂的开发.
研究的目的:
- 为了确定人类分离酶的小分子抑制剂.
- 在癌症模型中评估已识别的抑制剂的治疗潜力.
主要方法:
- 使用Chaetomium热分离酶蛋白酶域 (ctSPD) 对9,172种化合物的高通量选.
- 使用人类分离酶验证命中结果,随后进行微量热泳和分子动力学模拟.
- 基于细胞的测定和小鼠异种移植模型,以评估抗瘤疗效和安全性.
主要成果:
- 沃利辛B及其类型 (托克斯弗拉,3-甲基托克斯弗拉,3-托克斯弗拉) 被确定为人类强大的分离酶抑制剂.
- 瓦利辛B与活性部位结合,与基质竞争.
- 化合物诱导M相细胞周期停止,细胞亡和细胞死亡,在体内显示出显著的抗瘤活性,副作用最小.
结论:
- 瓦利辛B及其类型是人类分离酶的有效抑制剂,具有已证明的抗瘤潜力.
- 这些化合物代表了癌症治疗的有希望的候选人,以及用于分离研究的有价值的化学工具.
相关概念视频
02:34Inhibition of Cdk Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
02:43Mouse Models of Cancer Study
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...